Market Overview

UPDATE: Deutsche Bank Upgrades Mednax to Hold, Raises PT

Related MD
MEDNAX Agrees To Buy Cardon Outreach For $400 Million
Mednax's Unit MedData To Buy Duet Health For Undisclosed Terms
Midland and SOQUEM Identify New Targets on Casault and Resume Drilling (GuruFocus)

In a report published Friday, Deutsche Bank upgraded its rating on Mednax (NYSE: MD) from Sell to Hold, and raised its price target from $65.00 to $76.00.

Deutsche Bank noted, “MD's last two quarters have significantly allayed our concerns about a steeper slow-down in NICU trends. The combination of better-than-expected NICU volumes and stronger margins force us to reconsider our more cautious view on MD's earnings power. We move to Hold (from Sell), and raise our PT to $76 ($65) on higher estimates and our year-end process to roll-forward valuations off the new out-year (2014).”

Mednax closed on Thursday at $73.41.

Latest Ratings for MD

Mar 2016Stifel NicolausMaintainsBuy
Mar 2016SusquehannaDowngradesPositiveNeutral
Oct 2015SunTrust Robinson HumphreyMaintainsNeutral

View More Analyst Ratings for MD
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Analyst Ratings


Related Articles (MD)

View Comments and Join the Discussion!